European Biotech Acquisition Corp (EBAC)
$11.27
$-0.44
(-3.76%)
As on 02-Mar-2023 16:00EDT
Market cap
$184 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
559.5
P/B Ratio
1.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-74.8
-
Debt to Equity
--
-
Book Value
$9.5
-
EPS
$0
-
Face value
--
-
Shares outstanding
13,209,900
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
| 11.6 | 11.0 | 12.6 | 16.2 | -- | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
|
Company
|
2022
|
|---|---|
|
European Biotech Acquisition Corp (EBAC)
| 4.2 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
11.3 | 183.5 | 0.0 | 0.3 | -- | 0.6 | 559.5 | 1.3 |
| 10.1 | 295.9 | 0.0 | -7.4 | -- | -- | -- | 4.2 |
Shareholding Pattern
View DetailsAbout European Biotech Acquisition Corp (EBAC)
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or... entities. It intends to focus on business in the life sciences industry in Europe. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands. Read more
-
CEO & Director
Mr. Eduardo Bravo Fernandez de Araoz
-
CEO & Director
Mr. Eduardo Bravo Fernandez de Araoz
-
Headquarters
Amsterdam
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for European Biotech Acquisition Corp (EBAC)
What is the current share price of European Biotech Acquisition Corp (EBAC) Today?
The share price of European Biotech Acquisition Corp (EBAC) is $11.27 (NASDAQ) as of 02-Mar-2023 16:00 EDT. European Biotech Acquisition Corp (EBAC) has given a return of 16.19% in the last 1 years.
What is the current PB & PE ratio of European Biotech Acquisition Corp (EBAC)?
The P/E ratio of European Biotech Acquisition Corp (EBAC) is 559.50 times as on 02-Mar-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
375.69 |
1.06 |
2021 |
107.46 |
-23.76 |
2022 |
375.69 |
1.06 |
2021 |
107.46 |
-23.76 |
What is the 52 Week High and Low of European Biotech Acquisition Corp (EBAC)?
The 52-week high and low of European Biotech Acquisition Corp (EBAC) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of European Biotech Acquisition Corp (EBAC)?
European Biotech Acquisition Corp (EBAC) has a market capitalisation of $ 184 Mln as on 02-Mar-2023. As per SEBI classification, it is a company.
Should I invest in European Biotech Acquisition Corp (EBAC)?
Before investing in European Biotech Acquisition Corp (EBAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.